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2D models are failing to predict the accuracy and efficiency of cancer therapeutics. Thus 3D culture 
systems are adapted to unwind true structural and functional cancerous microenvironment. In situ, 
cancer microenvironment contains extracellular matrix (ECM) and diverse cells (stem and immune 
cells). The most abundant cancerous ECM is collagen, playing critical role in cancer metastasis. Silk 
protein fibroin is structurally homologous with collagen. Structural homology with naïve disease ECM 
and ability to adapt different morphologies as per prerequisites of application, enhances its prospect to 
be explored for cancer modelling and therapy. Porous silk sponges are able to serve as ECM support 
for breast and liver carcinoma, leading to development of functional solid hypoxic tumors with drug 
sensitivity. This improves the understanding of cell-ECM interaction in disease progression and 
therapeutic response. Stem cells are further incorporated within this hypoxic model to unwind the role 
of cellular cross-talk in cancer metastasis to secondary sites such as bone. Further, the structural 
diversity of silk biomaterials allows to deliver anti-cancer therapeutics by means of nanoparticle with 
target specificity imparted by folate conjugation. However, the exploitation of potential biopolymer like 
silk in cancer is at neonatal stage. Foreseen applications include mimicking of mechano-transducing 
cancerous ECM using flexibility and mechanical robustness of silk, designing of organ-on-a-chip and 
micro-tumors using silk. (Supported by Department of Biotechnology 
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